Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07269704 · ClinicalTrials.gov registry record · Early Phase 1
Effect of Nutritional Supplement Alpha-ketoglutarate for Age-related Ocular Disease
A Early Phase 1 study, sponsored by Stanford University.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 17
- Enrollment target
NCT07269704: Completed Early Phase 1 study, sponsored by Stanford University.
NCT07269704 is a Early Phase 1 study that has completed, run by Stanford University. The registered enrollment target is 17 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07269704, a Early Phase 1 study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 17 participants
- Enrollment target
Study Summary
The aims of the study are as follows: 1. Determine how the eye absorbs supplements taken orally. 2. Look for specific signs in the proteins and substances in the eyes of people with eye diseases who are also taking nutritional supplements.
Interventions
- DRUG Calcium alpha-ketoglutarate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2023-08-15 |
| Est. Completion | 2025-06-10 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07269704
The ClinicalTrials.gov registry entry for NCT07269704 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Calcium alpha-ketoglutarate is the first listed.
NCT07269704 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07269704 about?
NCT07269704 is a clinical study titled "Effect of Nutritional Supplement Alpha-ketoglutarate for Age-related Ocular Disease". The aims of the study are as follows: 1. Determine how the eye absorbs supplements taken orally. 2. Look for specific signs in the proteins and substances in the eyes of people with eye diseases who are also taking nutritional supplements.
What is the current status of trial NCT07269704?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 17 participants. The study started on 2023-08-15. Estimated completion is 2025-06-10.
What interventions are being tested in trial NCT07269704?
The interventions under investigation include: Calcium alpha-ketoglutarate (DRUG).
Who is sponsoring clinical trial NCT07269704?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.